|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's range||460.90 - 474.70|
|52-week range||376.00 - 631.60|
|Beta (5Y monthly)||0.27|
|PE ratio (TTM)||139.72|
|Forward dividend & yield||0.71 (0.12%)|
|Ex-dividend date||29 Mar 2021|
|1y target est||N/A|
MILFORD, Mass. & GOETTINGEN, Germany, October 27, 2021--Waters and Sartorius Partner to Help Bioprocess Scientists Accelerate Clone Selection and Process Development
SARTORIUS AG (SARTF) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Bio-Rad's equity position in a German pharma company is an asset many investors may not realize.